168 related articles for article (PubMed ID: 28978133)
1. In-depth phenotyping of lymphoblastoid cells suggests selective cellular vulnerability in Marinesco-Sjögren syndrome.
Kollipara L; Buchkremer S; Coraspe JAG; Hathazi D; Senderek J; Weis J; Zahedi RP; Roos A
Oncotarget; 2017 Sep; 8(40):68493-68516. PubMed ID: 28978133
[TBL] [Abstract][Full Text] [Related]
2. Cellular Signature of SIL1 Depletion: Disease Pathogenesis due to Alterations in Protein Composition Beyond the ER Machinery.
Roos A; Kollipara L; Buchkremer S; Labisch T; Brauers E; Gatz C; Lentz C; Gerardo-Nava J; Weis J; Zahedi RP
Mol Neurobiol; 2016 Oct; 53(8):5527-41. PubMed ID: 26468156
[TBL] [Abstract][Full Text] [Related]
3. SIL1 deficiency causes degenerative changes of peripheral nerves and neuromuscular junctions in fish, mice and human.
Phan V; Cox D; Cipriani S; Spendiff S; Buchkremer S; O'Connor E; Horvath R; Goebel HH; Hathazi D; Lochmüller H; Straka T; Rudolf R; Weis J; Roos A
Neurobiol Dis; 2019 Apr; 124():218-229. PubMed ID: 30468864
[TBL] [Abstract][Full Text] [Related]
4. Myopathy in Marinesco-Sjögren syndrome links endoplasmic reticulum chaperone dysfunction to nuclear envelope pathology.
Roos A; Buchkremer S; Kollipara L; Labisch T; Gatz C; Zitzelsberger M; Brauers E; Nolte K; Schröder JM; Kirschner J; Jesse CM; Goebel HH; Goswami A; Zimmermann R; Zahedi RP; Senderek J; Weis J
Acta Neuropathol; 2014 May; 127(5):761-77. PubMed ID: 24362440
[TBL] [Abstract][Full Text] [Related]
5. Sil1-Mutant Mice Elucidate Chaperone Function in Neurological Disorders.
Buchkremer S; González Coraspe JA; Weis J; Roos A
J Neuromuscul Dis; 2016 May; 3(2):169-181. PubMed ID: 27854219
[TBL] [Abstract][Full Text] [Related]
6. SIL1 mutations and clinical spectrum in patients with Marinesco-Sjogren syndrome.
Krieger M; Roos A; Stendel C; Claeys KG; Sonmez FM; Baudis M; Bauer P; Bornemann A; de Goede C; Dufke A; Finkel RS; Goebel HH; Häussler M; Kingston H; Kirschner J; Medne L; Muschke P; Rivier F; Rudnik-Schöneborn S; Spengler S; Inzana F; Stanzial F; Benedicenti F; Synofzik M; Lia Taratuto A; Pirra L; Tay SK; Topaloglu H; Uyanik G; Wand D; Williams D; Zerres K; Weis J; Senderek J
Brain; 2013 Dec; 136(Pt 12):3634-44. PubMed ID: 24176978
[TBL] [Abstract][Full Text] [Related]
7. Proteomic Analysis of Marinesco-Sjogren Syndrome Fibroblasts Indicates Pro-Survival Metabolic Adaptation to SIL1 Loss.
Potenza F; Cufaro MC; Di Biase L; Panella V; Di Campli A; Ruggieri AG; Dufrusine B; Restelli E; Pietrangelo L; Protasi F; Pieragostino D; De Laurenzi V; Federici L; Chiesa R; Sallese M
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830330
[TBL] [Abstract][Full Text] [Related]
8. PERK inhibition attenuates the abnormalities of the secretory pathway and the increased apoptotic rate induced by SIL1 knockdown in HeLa cells.
Capone V; Clemente E; Restelli E; Di Campli A; Sperduti S; Ornaghi F; Pietrangelo L; Protasi F; Chiesa R; Sallese M
Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3164-3180. PubMed ID: 30293566
[TBL] [Abstract][Full Text] [Related]
9. SIL1, the endoplasmic-reticulum-localized BiP co-chaperone, plays a crucial role in maintaining skeletal muscle proteostasis and physiology.
Ichhaporia VP; Kim J; Kavdia K; Vogel P; Horner L; Frase S; Hendershot LM
Dis Model Mech; 2018 May; 11(5):. PubMed ID: 29666155
[TBL] [Abstract][Full Text] [Related]
10. Targeting the enhanced ER stress response in Marinesco-Sjögren syndrome.
Kashimada A; Hasegawa S; Isagai T; Uchiyama T; Matsuo M; Kawai M; Goto M; Morio T; Hayashi YK; Takagi M
J Neurol Sci; 2018 Feb; 385():49-56. PubMed ID: 29406913
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Zebrafish Models of Marinesco-Sjögren Syndrome.
Kawahara G; Hayashi YK
PLoS One; 2016; 11(10):e0165563. PubMed ID: 27792754
[TBL] [Abstract][Full Text] [Related]
12. Identification of Cellular Pathogenicity Markers for SIL1 Mutations Linked to Marinesco-Sjögren Syndrome.
Gatz C; Hathazi D; Münchberg U; Buchkremer S; Labisch T; Munro B; Horvath R; Töpf A; Weis J; Roos A
Front Neurol; 2019; 10():562. PubMed ID: 31258504
[No Abstract] [Full Text] [Related]
13. Alteration of the unfolded protein response modifies neurodegeneration in a mouse model of Marinesco-Sjögren syndrome.
Zhao L; Rosales C; Seburn K; Ron D; Ackerman SL
Hum Mol Genet; 2010 Jan; 19(1):25-35. PubMed ID: 19801575
[TBL] [Abstract][Full Text] [Related]
14. C-terminal mutations destabilize SIL1/BAP and can cause Marinesco-Sjögren syndrome.
Howes J; Shimizu Y; Feige MJ; Hendershot LM
J Biol Chem; 2012 Mar; 287(11):8552-60. PubMed ID: 22219183
[TBL] [Abstract][Full Text] [Related]
15. PERK inhibition delays neurodegeneration and improves motor function in a mouse model of Marinesco-Sjögren syndrome.
Grande V; Ornaghi F; Comerio L; Restelli E; Masone A; Corbelli A; Tolomeo D; Capone V; Axten JM; Laping NJ; Fiordaliso F; Sallese M; Chiesa R
Hum Mol Genet; 2018 Jul; 27(14):2477-2489. PubMed ID: 29718201
[TBL] [Abstract][Full Text] [Related]
16. Sil1, a nucleotide exchange factor for BiP, is not required for antibody assembly or secretion.
Ichhaporia VP; Sanford T; Howes J; Marion TN; Hendershot LM
Mol Biol Cell; 2015 Feb; 26(3):420-9. PubMed ID: 25473114
[TBL] [Abstract][Full Text] [Related]
17. Phenotype-genotype correlations in patients with Marinesco-Sjögren syndrome.
Ezgu F; Krejci P; Li S; de Sousa C; Graham JM; Hansmann I; He W; Porpora K; Wand D; Wertelecki W; Schneider A; Wilcox WR
Clin Genet; 2014 Jul; 86(1):74-84. PubMed ID: 23829326
[TBL] [Abstract][Full Text] [Related]
18. Marinesco-Sjögren syndrome protein SIL1 regulates motor neuron subtype-selective ER stress in ALS.
Filézac de L'Etang A; Maharjan N; Cordeiro Braña M; Ruegsegger C; Rehmann R; Goswami A; Roos A; Troost D; Schneider BL; Weis J; Saxena S
Nat Neurosci; 2015 Feb; 18(2):227-38. PubMed ID: 25559081
[TBL] [Abstract][Full Text] [Related]
19. Tracking Effects of SIL1 Increase: Taking a Closer Look Beyond the Consequences of Elevated Expression Level.
Labisch T; Buchkremer S; Phan V; Kollipara L; Gatz C; Lentz C; Nolte K; Vervoorts J; Coraspe JAG; Sickmann A; Carr S; Zahedi RP; Weis J; Roos A
Mol Neurobiol; 2018 Mar; 55(3):2524-2546. PubMed ID: 28401474
[TBL] [Abstract][Full Text] [Related]
20. Loss of SIL1 Affects Actin Dynamics and Leads to Abnormal Neural Migration.
Xu Y; Sun H; Chen J; Qin L; Wu M; Zhong Z; Zhang X
Mol Neurobiol; 2024 Jun; ():. PubMed ID: 38850350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
